Do I need to fast during Pitobrutinib treatment?

Pirtobrutinib is a non-covalent (reversible) Brutontyrosine kinase (BTK) inhibitor, mainly used for treatment Relapsed or refractory Bcell lymphoma, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Patients usually pay attention to whether they need to fast while taking the drug to ensure optimal absorption and efficacy of the drug.

First, the way pitobrutinib is taken is not affected by food. Based on clinical studies and labeling, this drug can be taken with or without food and does not significantly alter its absorption or bioavailability due to ingestion of food. This means that patients can choose the most comfortable time to take medication based on their personal habits without having to fast.

Secondly, although eating will not affect the efficacy of pitobrutinib, a reasonable diet can help reduce gastrointestinal adverse reactions. Some patients may experience nausea, diarrhea or mild stomach discomfort during treatment. In this case, they can choose to take it with food to avoid irritation to the stomach if taken on an empty stomach. At the same time, it is recommended to avoid high-fat, high-sugar or overly irritating foods to reduce digestive system discomfort.

Finally, patients should follow their doctor's specific recommendations if they have special conditions (such as severe gastrointestinal reactions or are taking other medications that may affect drug absorption). During the entire treatment process, maintaining a balanced diet, reasonable work and rest, and paying attention to water intake will help to better manage side effects and improve the tolerance and therapeutic effect of pitobrutinib.

xa0

Reference materials:https://www.jaypirca.com/